Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Debt (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Total Debt for 6 consecutive years, with $460.8 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Debt fell 9.57% year-over-year to $460.8 million, compared with a TTM value of $460.8 million through Dec 2024, down 9.57%, and an annual FY2024 reading of $460.8 million, down 9.57% over the prior year.
  • Total Debt was $460.8 million for Q4 2024 at Cresco Labs, down from $509.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $509.5 million in Q4 2023 and bottomed at $281.4 million in Q4 2020.
  • Average Total Debt over 5 years is $444.9 million, with a median of $485.0 million recorded in 2021.
  • The sharpest move saw Total Debt soared 51056.91% in 2020, then dropped 9.57% in 2024.
  • Year by year, Total Debt stood at $281.4 million in 2020, then skyrocketed by 72.38% to $485.0 million in 2021, then increased by 0.59% to $487.9 million in 2022, then grew by 4.44% to $509.5 million in 2023, then dropped by 9.57% to $460.8 million in 2024.
  • Business Quant data shows Total Debt for CRLBF at $460.8 million in Q4 2024, $509.5 million in Q4 2023, and $487.9 million in Q4 2022.